In mice with MCD diet-induced NASH, glycyrrhizin and its metabolite glycyrrhetinic acid can significantly decrease bile acids accumulation, thus inhibiting the activation of NLRP3 inflammasome to attenuate liver fibrosis (Yan et al., 2018). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.